Genomics Aotearoa

Company

Last mentioned: Mar 18, 2026

Timeline

Q1 2027
Interim Review

Assessment of clinical utility and cost-effectiveness for long-term funding.
Mar 18, 2026
Trial Launch

Official commencement of patient recruitment for cancer and rare disorder cohorts.
2026
Data Integration

First wave of genomic data integrated into clinical health records for treatment matching.
Q4 2025
Infrastructure Setup

Accreditation of local laboratories and installation of high-throughput sequencers.

Stories mentioning Genomics Aotearoa 1

New Zealand Launches Landmark Genomic Trial for Cancer and Rare Disorders

New Zealand has initiated a major genomic medicine trial designed to provide locally-based genetic sequencing for patients battling cancer and rare diseases. By repatriating diagnostic capabilities, the program aims to accelerate treatment timelines and improve health equity across the country's diverse populations.

Mar 18, 2026 2 sources